Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novartis AG Graphic](https://lunarcrush.com/gi/w:26/t:$novnsw.png) Novartis AG

Novartis's Pluvicto reduces the risk of progression or death in prostate cancer by 28%. The company also faces potential US price cuts and patent issues.

### About Novartis AG
Novartis AG is a global pharmaceutical company.  

### Insights [#](/topic/$novnsw/insights)
- Novartis AG engagements is up XXXXX% from the previous week.

### Price: $ [#](/topic/$novnsw/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/close.tsv)  
The price action is likely influenced by the positive news regarding Kesimpta and the company's investments, but the uncertainty around US price cuts and potential tariffs could be creating some volatility, as the price hit an all time high of XXXXXX for the hour.  

**1-Year High**: $XXXXXX on 2025-10-09  
**1-Year Low**: $XX on 2025-04-09  
  
  
### AltRank: undefined [#](/topic/$novnsw/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/alt_rank.tsv)  
Novartis AG is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXX  
**1-Year High**: XXX on 2025-04-01  
**1-Year Low**: XX on 2025-02-26  
  
  
### Galaxy Score: XX [#](/topic/$novnsw/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2025-03-07  
**1-Year Low**: XX on 2024-12-28  
  
  
### Engagements: XXXXXXX [#](/topic/$novnsw/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXXXX +20%  
**1 Month**: XXXXXXXXX -XX%  
**6 Months**: XXXXXXXXXX +86%  
**1 Year**: XXXXXXXXXX +51%  
**1-Year High**: XXXXXXXXX on 2025-08-26  
**1-Year Low**: XXXXXX on 2025-01-27  

| Social Network | News | Reddit | TikTok | X      | YouTube |
| -------------- | ---- | ------ | ------ | -      | ------- |
| Engagements    | XX   | XXX    | XXXXX  | XXXXXX | XXXXXXX |
  

  
  
### Mentions: XXX [#](/topic/$novnsw/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXXX +27%  
**1 Year**: XXXXXX +146%  
**1-Year High**: XXX on 2025-09-09  
**1-Year Low**: XX on 2024-11-11  

| Social Network | News | Reddit | TikTok | X   | YouTube |
| -------------- | ---- | ------ | ------ | -   | ------- |
| Mentions       | X    | XX     | XXX    | XXX | XXX     |
  

  
  
### Creators: XXX [#](/topic/$novnsw/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is up XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XX -XX%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +22%  
**1 Year**: XXXXX +165%  
**1-Year High**: XXX on 2025-09-09  
**1-Year Low**: XX on 2024-11-11  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                              | Rank | Followers  | Posts | Engagements |
| -------                                              | ---- | ---------  | ----- | ----------- |
| [@novartis](/creator/youtube/novartis)               | X    | XXXXXX     | XX    | XXXXXXX     |
| [@FeeRedfern](/creator/twitter/FeeRedfern)           | X    | XXXXX      | X     | XXXXXX      |
| [@HealthPolicyW](/creator/twitter/HealthPolicyW)     | X    | XXXXXX     | X     | XXXXX       |
| [@theplayerstv](/creator/tiktok/theplayerstv)        | X    | XXXXXX     | X     | XXXXX       |
| [@ValueSense_io](/creator/twitter/ValueSense_io)     | X    | XXXXXX     | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)       | X    | XXX        | XX    | XXXXX       |
| [@TheIndexInsider](/creator/twitter/TheIndexInsider) | X    | XXXXX      | X     | XXX         |
| [@Reuters](/creator/twitter/Reuters)                 | X    | XXXXXXXXXX | X     | XXX         |
| [@TuwilikaNafuka](/creator/twitter/TuwilikaNafuka)   | X    | XXXXX      | X     | XXX         |
| [@Reuters_Health](/creator/twitter/Reuters_Health)   | XX   | XXXXXXX    | X     | XXX         |

[View More](/list/creators/$novnsw/100)
  
  
### Sentiment: XX% [#](/topic/$novnsw/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +10%  
**6 Months**: XX% +10%  
**1 Year**: XX% +5%  
**1-Year High**: XX% on 2024-11-16  
**1-Year Low**: XX% on 2025-08-26  

**Most Supportive Themes**
- **Kesimpta Benefits:** (35%) Positive data supporting the benefits of Kesimpta in relapsing multiple sclerosis (RMS) is being shared across multiple social networks.
- **Novartis's Innovation and Investment:** (20%) Mentions of Novartis's investments in R&D and acquisitions, such as Regulus Therapeutics, are generating positive sentiment.
- **Access to Medicines:** (15%) Positive sentiment around Novartis's efforts to provide access to medicines, particularly in collaboration with organizations like the UICC.
  
**Most Critical Themes**
- **US Price Cuts:** (10%)  Discussions around potential price cuts in the US market, driven by CEO comments and potential tariff impacts, are generating some critical sentiment.
- **Patent Revocation:** (5%)  The revocation of Novartis's patent for Vymada in India is a critical point.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %  | Negative | %  |
| ------- | -------- | -   | ------- | -  | -------- | -  |
| News    | X        | X%  | XX      | X% | X        | X% |
| Reddit  | XXX      | X%  | XXX     | X% | XXX      | X% |
| TikTok  | XXXXX    | X%  | XXXXX   | X% | XXX      | X% |
| X       | XXXXXX   | X%  | XXXXXX  | X% | XXXXX    | X% |
| YouTube | XXXXXXX  | XX% | XXXXX   | X% | XXX      | X% |
|         |          |     |         |    |          |    |
| Total   | XXXXXXX  | XX% | XXXXXX  | X% | XXXXX    | X% |
  

  
  
### Market Cap: $undefined [#](/topic/$novnsw/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXXX on 2024-10-28  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-20  

**Top assets mentioned**
In the posts about Novartis AG in the last XX hours

[Novartis AG (NVS)](/topic/novartis)
[Novartis AG (NVS)](/topic/$nvs)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[AstraZeneca PLC (AZN)](/topic/$azn)
[ROGin AI (ROG)](/topic/$rog)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Sanofi (SNY)](/topic/sanofi)

**Top topics mentioned**
In the posts about Novartis AG in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [switzerland](/topic/switzerland), [stocks technology](/topic/stocks-technology), [stocks financial services](/topic/stocks-financial-services), [$nvs](/topic/$nvs), [$novn](/topic/$novn), [$mrk](/topic/$mrk), [$pfe](/topic/$pfe), [$azn](/topic/$azn), [$nesn](/topic/$nesn), [stocks banks](/topic/stocks-banks), [$rog](/topic/$rog), [stocks communication services](/topic/stocks-communication-services), [adobe](/topic/adobe), [$efgn](/topic/$efgn), [investment](/topic/investment), [$novcde](/topic/$novcde), [$googl](/topic/$googl), [eli lilly](/topic/eli-lilly), [$abbv](/topic/$abbv), [sanofi](/topic/sanofi), [$ubs](/topic/$ubs), [stocks industrials](/topic/stocks-industrials), [$amgn](/topic/$amgn), [microsoft](/topic/microsoft), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$ubsg](/topic/$ubsg), [ibm](/topic/ibm), [india](/topic/india), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$anet](/topic/$anet), [$panw](/topic/$panw), [youtube](/topic/youtube), [netapp](/topic/netapp), [$sdzsw](/topic/$sdzsw), [$nvo](/topic/$nvo), [breast cancer](/topic/breast-cancer), [$sren](/topic/$sren), [tariffs](/topic/tariffs), [has been](/topic/has-been), [taiwan semiconductor](/topic/taiwan-semiconductor), [$tsm](/topic/$tsm), [taiwan](/topic/taiwan), [honeywell](/topic/honeywell), [vas](/topic/vas), [jersey](/topic/jersey), [johnson johnson](/topic/johnson-johnson), [$infy](/topic/$infy), [swiss](/topic/swiss), [$abbn](/topic/$abbn), [abbott laboratories](/topic/abbott-laboratories), [$abt](/topic/$abt), [$qcom](/topic/$qcom), [alto](/topic/alto), [$ipnpa](/topic/$ipnpa), [future of](/topic/future-of), [$issc](/topic/$issc), [adobe inc](/topic/adobe-inc), [$adbe](/topic/$adbe), [$zurn](/topic/$zurn), [sap](/topic/sap), [$uber](/topic/$uber), [$mu](/topic/$mu), [donald trump](/topic/donald-trump), [$baynsg](/topic/$baynsg), [$gmabco](/topic/$gmabco), [approved](/topic/approved), [insurance](/topic/insurance), [novo](/topic/novo), [gilead sciences](/topic/gilead-sciences), [chanel](/topic/chanel), [zurich](/topic/zurich), [$bmy](/topic/$bmy), [rog](/topic/rog), [$torntpharmns](/topic/$torntpharmns), [money](/topic/money), [$unh](/topic/$unh), [$csco](/topic/$csco), [asml](/topic/asml), [w wayfair inc](/topic/w-wayfair-inc), [careers](/topic/careers), [meta](/topic/meta), [cullenfrost bankers inc](/topic/cullenfrost-bankers-inc), [$cfr](/topic/$cfr), [salesforce](/topic/salesforce), [$crm](/topic/$crm), [$galdsw](/topic/$galdsw), [$gald](/topic/$gald), [coins solana ecosystem](/topic/coins-solana-ecosystem), [sap se](/topic/sap-se), [$sap](/topic/$sap), [united states](/topic/united-states), [networks](/topic/networks), [head of](/topic/head-of), [$lonnsw](/topic/$lonnsw), [$sdz](/topic/$sdz), [$rhhby](/topic/$rhhby), [coins bsc](/topic/coins-bsc), [$heln](/topic/$heln)

### Top Social Posts [#](/topic/$novnsw/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Creating one job in the life sciences industry creates X jobs globally explains @Novartis Patrick Horber. Thats just one example of the ripple effect of funding medical innovation. 🎧 Listen to his discussion with @riskindan and @Lazard's David Gluckman on The Ripple Effect podcast from GZERO & Novartis:"  
[X Link](https://x.com/gzeromedia/status/1980631776692208065) [@gzeromedia](/creator/x/gzeromedia) 2025-10-21T13:46Z 67.4K followers, XXX engagements


"@MylesMcNulty @PTarantinoMD @myESMO @avacta Novartis Novartis and maybe Novartis 😂"  
[X Link](https://x.com/gilesgeddes/status/1980615447343939799) [@gilesgeddes](/creator/x/gilesgeddes) 2025-10-21T12:41Z XXX followers, XXX engagements


"Not long until the Tumour Models Summit in London on 3rd-4th December. #AVCT are 'recently registered' along with AstraZeneca. Novartis is also attending too"  
[X Link](https://x.com/tom_the_bomb__/status/1980614474739642467) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-21T12:37Z 3315 followers, 2693 engagements


"CEO 1.CEO of Alphabet Google 2.CEO of Microsoft 3.CEO of YouTube 4.CEO of Adobe 5.CEO of World Bank Group 6.CEO of IBM 7.CEO of Albertsons 8.CEO of Infosys 9.CEO of NetApp 10.CEO of Palo Alto Networks 11.CEO of Arista Networks 12.CEO of Novartis 13.CEO of Micron Technology 14.CEO of Honeywell 15.CEO of Flex 16.CEO of Wayfair 17.CEO of Chanel 18.CEO of Cognizant Note: citizens of India citizens of other countries but born in India Indian origin or with Indian parents"  
[X Link](https://x.com/TheIndexInsider/status/1980614428879102141) [@TheIndexInsider](/creator/x/TheIndexInsider) 2025-10-21T12:37Z 2554 followers, 1899 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Novartis AG Graphic Novartis AG

Novartis's Pluvicto reduces the risk of progression or death in prostate cancer by 28%. The company also faces potential US price cuts and patent issues.

About Novartis AG

Novartis AG is a global pharmaceutical company.

Insights #

  • Novartis AG engagements is up XXXXX% from the previous week.

Price: $ #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by the positive news regarding Kesimpta and the company's investments, but the uncertainty around US price cuts and potential tariffs could be creating some volatility, as the price hit an all time high of XXXXXX for the hour.

1-Year High: $XXXXXX on 2025-10-09
1-Year Low: $XX on 2025-04-09

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novartis AG is currently AltRank #undefined based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXX on 2025-04-01
1-Year Low: XX on 2025-02-26

Galaxy Score: XX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-07
1-Year Low: XX on 2024-12-28

Engagements: XXXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX +20%
1 Month: XXXXXXXXX -XX%
6 Months: XXXXXXXXXX +86%
1 Year: XXXXXXXXXX +51%
1-Year High: XXXXXXXXX on 2025-08-26
1-Year Low: XXXXXX on 2025-01-27

Social Network News Reddit TikTok X YouTube
Engagements XX XXX XXXXX XXXXXX XXXXXXX

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXXX +27%
1 Year: XXXXXX +146%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-11-11

Social Network News Reddit TikTok X YouTube
Mentions X XX XXX XXX XXX

Creators: XXX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is up XX% from XXX in the previous XX hours Daily Average: XXX
1 Week: XX -XX%
1 Month: XXX -XX%
6 Months: XXXXX +22%
1 Year: XXXXX +165%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-11-11

The most influential creators that mention Novartis AG in the last XX hours

Creator Rank Followers Posts Engagements
@novartis X XXXXXX XX XXXXXXX
@FeeRedfern X XXXXX X XXXXXX
@HealthPolicyW X XXXXXX X XXXXX
@theplayerstv X XXXXXX X XXXXX
@ValueSense_io X XXXXXX X XXXXX
@Darwin_Knows X XXX XX XXXXX
@TheIndexInsider X XXXXX X XXX
@Reuters X XXXXXXXXXX X XXX
@TuwilikaNafuka X XXXXX X XXX
@Reuters_Health XX XXXXXXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +10%
6 Months: XX% +10%
1 Year: XX% +5%
1-Year High: XX% on 2024-11-16
1-Year Low: XX% on 2025-08-26

Most Supportive Themes

  • Kesimpta Benefits: (35%) Positive data supporting the benefits of Kesimpta in relapsing multiple sclerosis (RMS) is being shared across multiple social networks.
  • Novartis's Innovation and Investment: (20%) Mentions of Novartis's investments in R&D and acquisitions, such as Regulus Therapeutics, are generating positive sentiment.
  • Access to Medicines: (15%) Positive sentiment around Novartis's efforts to provide access to medicines, particularly in collaboration with organizations like the UICC.

Most Critical Themes

  • US Price Cuts: (10%) Discussions around potential price cuts in the US market, driven by CEO comments and potential tariff impacts, are generating some critical sentiment.
  • Patent Revocation: (5%) The revocation of Novartis's patent for Vymada in India is a critical point.

Network engagement breakdown:

Network Positive % Neutral % Negative %
News X X% XX X% X X%
Reddit XXX X% XXX X% XXX X%
TikTok XXXXX X% XXXXX X% XXX X%
X XXXXXX X% XXXXXX X% XXXXX X%
YouTube XXXXXXX XX% XXXXX X% XXX X%
Total XXXXXXX XX% XXXXXX X% XXXXX X%

Market Cap: $undefined #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-28
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-20

Top assets mentioned In the posts about Novartis AG in the last XX hours

Novartis AG (NVS) Novartis AG (NVS) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) ROGin AI (ROG) Alphabet Inc Class A (GOOGL) Eli Lilly and Company (LLY) AbbVie Inc (ABBV) Sanofi (SNY)

Top topics mentioned In the posts about Novartis AG in the last XX hours

stocks healthcare, stocks, switzerland, stocks technology, stocks financial services, $nvs, $novn, $mrk, $pfe, $azn, $nesn, stocks banks, $rog, stocks communication services, adobe, $efgn, investment, $novcde, $googl, eli lilly, $abbv, sanofi, $ubs, stocks industrials, $amgn, microsoft, stocks consumer cyclical, $ubsg, ibm, india, stocks consumer defensive, $anet, $panw, youtube, netapp, $sdzsw, $nvo, breast cancer, $sren, tariffs, has been, taiwan semiconductor, $tsm, taiwan, honeywell, vas, jersey, johnson johnson, $infy, swiss, $abbn, abbott laboratories, $abt, $qcom, alto, $ipnpa, future of, $issc, adobe inc, $adbe, $zurn, sap, $uber, $mu, donald trump, $baynsg, $gmabco, approved, insurance, novo, gilead sciences, chanel, zurich, $bmy, rog, $torntpharmns, money, $unh, $csco, asml, w wayfair inc, careers, meta, cullenfrost bankers inc, $cfr, salesforce, $crm, $galdsw, $gald, coins solana ecosystem, sap se, $sap, united states, networks, head of, $lonnsw, $sdz, $rhhby, coins bsc, $heln

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Creating one job in the life sciences industry creates X jobs globally explains @Novartis Patrick Horber. Thats just one example of the ripple effect of funding medical innovation. 🎧 Listen to his discussion with @riskindan and @Lazard's David Gluckman on The Ripple Effect podcast from GZERO & Novartis:"
X Link @gzeromedia 2025-10-21T13:46Z 67.4K followers, XXX engagements

"@MylesMcNulty @PTarantinoMD @myESMO @avacta Novartis Novartis and maybe Novartis 😂"
X Link @gilesgeddes 2025-10-21T12:41Z XXX followers, XXX engagements

"Not long until the Tumour Models Summit in London on 3rd-4th December. #AVCT are 'recently registered' along with AstraZeneca. Novartis is also attending too"
X Link @tom_the_bomb__ 2025-10-21T12:37Z 3315 followers, 2693 engagements

"CEO 1.CEO of Alphabet Google 2.CEO of Microsoft 3.CEO of YouTube 4.CEO of Adobe 5.CEO of World Bank Group 6.CEO of IBM 7.CEO of Albertsons 8.CEO of Infosys 9.CEO of NetApp 10.CEO of Palo Alto Networks 11.CEO of Arista Networks 12.CEO of Novartis 13.CEO of Micron Technology 14.CEO of Honeywell 15.CEO of Flex 16.CEO of Wayfair 17.CEO of Chanel 18.CEO of Cognizant Note: citizens of India citizens of other countries but born in India Indian origin or with Indian parents"
X Link @TheIndexInsider 2025-10-21T12:37Z 2554 followers, 1899 engagements

Novartis AG
/topic/$novnsw